Berberine vs Ozempic and GLP-1 medications: clinical evidence comparison. Is berberine really 'nature's Ozempic'? The data examined.
A July 2026 JAMA study found 45 of 49 GLP-1 telehealth platforms had minimal clinical oversight. Here's the actual breakdown, not the sanitized version.
Many GLP-1 telehealth 'brands' are storefronts owned by the same parent company. Here's how to actually check ownership before assuming independent competition.
The advertised GLP-1 price is rarely your real cost. Here's every line item to add up before comparing providers.
What happens to your money if a GLP-1 medication doesn't work for you? Here's what to actually ask before your first order.
Provider comparisons that never get updated mislead readers. Here's our accountability update on what's actually changed since our last review cycle.
Fast GLP-1 approval isn't automatically a red flag - but it can be. Here's how to tell legitimate efficiency from skipped clinical review.
Telehealth platforms rarely specify whether an MD or NP reviews your case. Here's the actual distinction and what to ask before you commit.
Some GLP-1 providers charge a separate membership fee. Here's what it's actually supposed to cover and how to tell if it's worth it.
When can you expect to see results on semaglutide, tirzepatide, or orforglipron? We compare timelines from clinical trial data.
Oxford's BMJ meta-analysis found weight regain of 0.9 lbs/month after stopping GLP-1s. Here's what the data says — and how to plan for it.
Every provider promises a personalized treatment plan. We investigated what 'personalized' actually means — and what it doesn't.
Telehealth is faster and cheaper. In-person gives you lab work and physical exams. Here's how to decide which is right for your situation.
We read the cancellation terms of every major GLP-1 program. Some let you walk away anytime. Others make Planet Fitness look flexible.
We tested response times, escalation paths, and whether you can actually reach a human when something goes wrong.
Semaglutide (Wegovy/Ozempic) vs tirzepatide (Zepbound/Mounjaro): efficacy, side effects, cost, and availability compared for June 2026.
775+ adverse events from compounded GLP-1. Here's how to tell if your telehealth provider is legitimate — and when to walk away.
Eli Lilly's triple-hormone drug is the most effective weight loss medication ever tested. It's also 2+ years away. Here's why starting now is smarter.
Two GLP-1 pills, very different rules. We compare orforglipron (Foundayo) and oral Wegovy on dosing, efficacy, convenience, and pricing.
May 2026 NIH study: oral GLP-1 pills suppress eating for pleasure via deep brain pathways. Different mechanism than injectables.
CMS launches $50/mo GLP-1 access for Medicare July 2026. We read every line of the announcement so you don't have to.
Most sites show starting prices. We show what you'll actually pay at maintenance dose. Complete GLP-1 pricing at every titration step.
Prices dropped, pills launched, Medicare joined. The competitive landscape for GLP-1 medications has never been more favorable for patients.
The April 30, 2026 FDA proposal to remove GLP-1s from the 503B Bulks List. We break down who benefits, who loses, and what it means for your medication.
Compounded GLP-1 costs 50-80% less than brand. But is it the same medication? We compare cost, safety, legality, and efficacy with actual numbers.
75-80% weight maintenance sounds good. But what about the 20-25% you lose? We analyze the ATTAIN-MAINTAIN data honestly.
Eli Lilly's TRIUMPH-1 data shows retatrutide delivers 28% weight loss — rivaling bariatric surgery. What this triple agonist means for the future.
Supply chain reports from the front lines. Which providers are shipping on time and which are stalling — and what that means for your treatment.
Most GLP-1 ads show starting-dose prices. Here's what you'll actually pay at maintenance dose across 12 telehealth providers.
Two GLP-1 pills, different trade-offs. Oral semaglutide has higher efficacy but strict fasting rules. Foundayo is flexible but less potent.
Both formats work. Neither is universally better. Here's what the evidence actually says — without the spin.
New NIH research reveals the molecular pathways behind GLP-1 weight loss — and why some patients respond better than others.
Medicare Part D beneficiaries can access GLP-1 medications for $50/month starting July 1. Here's how the Bridge program works and who qualifies.
LegitScript certification separates vetted telehealth providers from the rest. Here's what it verifies and which GLP-1 platforms have it.
Our quarterly assessment of the GLP-1 telehealth market. Which providers raised their standards — and which ones slipped.
With Foundayo, oral semaglutide, and injectable options all available, choosing a GLP-1 format matters. We compare efficacy, cost, and convenience.
GLP-1 influencer disclosure practices vary widely. Here's what's actually required and how to spot content that isn't playing it straight.
Switching GLP-1 providers doesn't mean starting over. Here's how to transfer your prescription, maintain your dose, and avoid gaps.
GLP-1 treatment isn't a 3-month fix — it's ongoing therapy. Here's how to calculate the real annual cost and find sustainable options.
Many GLP-1 telehealth companies are newer than their polished branding suggests. Here's how to check a provider's actual operating history in two minutes.
The advertised GLP-1 price is rarely the full cost. Here's what commonly shows up at checkout that the homepage number doesn't mention.
No legitimate GLP-1 provider can ethically guarantee your results. Here's why that specific marketing claim is a genuine red flag.
Most GLP-1 patients hit a plateau between months 6-12. Here's the science behind it and evidence-based strategies to push through.
Men respond differently to GLP-1 medications — faster initial loss, different side effect profiles, and unique muscle preservation needs.
The way your provider bills you affects more than your bank account. It shapes your flexibility, your risk, and your options if things change.
Nausea, fatigue, constipation — most GLP-1 side effects are temporary. But these symptoms require immediate medical attention.
Dozens of GLP-1 telehealth companies have already closed or pivoted. If yours is next, here's what happens to your treatment.
Not all GLP-1 telehealth providers are equal. These five red flags signal you should look elsewhere before committing.
We read the terms of service so you don't have to. What we found should change how you compare GLP-1 programs.
GLP-1 medications suppress appetite, but skipping protein accelerates muscle loss. Here's how much you need and why it matters.
Life changes. Your treatment needs change. Does your provider let you adapt — or do they penalize you for it?
15-20% of GLP-1 patients are non-responders. Here's why it happens and what your options are if you're not losing weight.
Lab work is the clearest signal of whether your provider is practicing medicine or just shipping medication. Here's what the best programs require.
Any provider that guarantees you'll lose a specific number of pounds is violating medical ethics. Here's what legitimate programs say instead.
GLP-1 medications slow gastric emptying, which can change how other drugs are absorbed. These interactions matter most.
GLP-1 medications treat both type 2 diabetes and obesity, but the prescribing approach differs. Here's what matters for each indication.
There's a massive gap between 'ongoing medical support' in the marketing and what actually happens after your first shipment arrives.
Rapid weight loss on GLP-1s can weaken bones. Women over 50 face the highest risk. Here's what to monitor and how to protect yourself.
Auto-refill schedules don't always match your actual usage. Here's how to avoid paying for medication you haven't used yet.
Exercise plus GLP-1 preserves muscle, boosts metabolism, and may improve long-term outcomes. Here's what the evidence supports.
Many GLP-1 users report dramatically reduced alcohol tolerance and cravings. Here's what the research says and what to watch for.
Eli Lilly's oral GLP-1 pill Foundayo starts at $149/mo. Compounded semaglutide starts at $99-159/mo. We compare the real costs at every stage.
What to expect in your first 30 days on semaglutide or tirzepatide — from side effects to appetite changes to your first weigh-in.
FDA warning letters are public record and one of the most useful provider-evaluation signals nobody checks. Here's what they mean and how to check them yourself.
The FDA proposes permanently excluding semaglutide, tirzepatide, and liraglutide from 503B bulk compounding. Comment period closes June 29, 2026.
Provider review sites are easy to manipulate. Here's how to actually spot fake or incentivized reviews versus genuine ones.
GLP-1 marketing is full of unsourced statistics. Here's how to actually tell verifiable claims from spin in under a few minutes.
We tried to independently verify the compounding pharmacy behind each major GLP-1 program. Some made it easy. Others made it impossible.
Your titration schedule affects your results and your side effects. Not all providers handle it the same way — and the differences matter.
Some GLP-1 pricing structures create a financial incentive for faster dose escalation. Here's what to watch for and how to ask about it directly.
Compounded GLP-1s cost 60-80% less but aren't FDA-approved. Brand-name versions have clinical trial backing. Here's how to choose.
Same molecule, very different products. Here's the honest comparison the industry doesn't want you to see.
Compounded and brand-name GLP-1 marketing both distort the comparison in their favor. Here's what's actually different, stripped of the spin.
Every provider promises results. We looked at what they actually deliver — and where the gaps are.
Signing up for a GLP-1 provider is instant. Canceling isn't always. Here's what to check before you commit.
BBB and state AG records are free, public, and rarely checked. Here's what a five-minute search actually reveals about a provider.
New real-world data from ASCO 2026 shows GLP-1 medications may reduce metastatic progression in lung, breast, colorectal, and liver cancers.
GLP-1 'as low as' pricing almost always refers to your first month at the lowest dose. Here's what your actual maintenance-dose cost will be.
The FDA's regulatory actions on 503B outsourcing facilities are reshaping the compounded GLP-1 market. Some providers saw it coming. Others didn't.
Your compounded GLP-1 comes from either a 503A or 503B pharmacy. The distinction affects quality, regulation, and future availability.